TrialsgrambetaRCTs are beautiful

Melanoma & skin cancers

2 trials
  • 2015CheckMate-067Advanced melanomaIn 945 patients with untreated advanced melanoma, nivolumab + ipilimumab or nivolumab improved overall survival compared with ipilimumab.
  • 2011BRIM-3BRAF-mutant melanomaIn 675 patients with BRAF V600E-mutant unresectable or metastatic melanoma, vemurafenib improved overall survival compared with dacarbazine.